What is the projected market valuation for the China drug infusion-system market in 2035?

The projected market valuation for the China drug infusion-system market in 2035 is $1312.0 Million. Read More

What was the overall market valuation in 2024?

The overall market valuation in 2024 was $740.25 Million. Read More

What is the expected CAGR for the China drug infusion-system market during the forecast period 2025 - 2035?

The expected CAGR for the China drug infusion-system market during the forecast period 2025 - 2035 is 5.34%. Read More

Which product type had the highest valuation in 2024?

In 2024, the disposable infusion system had the highest valuation at $148.06 Million. Read More

What is the projected valuation for the oncology/chemotherapy application by 2035?

The projected valuation for the oncology/chemotherapy application by 2035 is $263.0 Million. Read More

Which end-user segment is expected to dominate the market in 2035?

The hospitals segment is expected to dominate the market in 2035 with a projected valuation of $683.4 Million. Read More

What was the valuation of the insulin pump segment in 2024?

The valuation of the insulin pump segment in 2024 was $37.01 Million. Read More

Which key player is known for its leadership in the drug infusion-system market?

Baxter International is recognized for its leadership in the drug infusion-system market. Read More

What is the projected valuation for the multi-channel pump segment by 2035?

The projected valuation for the multi-channel pump segment by 2035 is $130.0 Million. Read More

How does the valuation of the subcutaneous mode of administration compare in 2024 and 2035?

The valuation of the subcutaneous mode of administration is expected to increase from $148.05 Million in 2024 to $250.0 Million in 2035. Read More

China Drug Infusion System Market

ID: MRFR/Pharma/54782-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

China Drug Infusion System Market Research Report By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Application (Oncology/Chemotherapy), By Mode of Administration (Intravenous), andBy End User (Hospitals) - Growth & Industry Forecast 2025 To 2035

China Drug Infusion System Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Product Type (USD Million)
  1. 4.1.1 Elastomeric infusion system
  2. 4.1.2 Disposable infusion system
  3. 4.1.3 Syringe infusion system
  4. 4.1.4 Peristaltic pump
  5. 4.1.5 Multi-channel pump
  6. 4.1.6 Patient-Controlled Analgesia (PCA) pump
  7. 4.1.7 Insulin pump
  8. 4.1.8 Implantable infusion system
2. 4.2 Pharmaceutical, BY Application (USD Million)
  1. 4.2.1 Oncology/Chemotherapy
  2. 4.2.2 Diabetes
  3. 4.2.3 Analgesia
  4. 4.2.4 Nutrition
  5. 4.2.5 Hematology
  6. 4.2.6 Pediatrics
  7. 4.2.7 Others
3. 4.3 Pharmaceutical, BY Mode of administration (USD Million)
  1. 4.3.1 Intravenous
  2. 4.3.2 Subcutaneous
  3. 4.3.3 Arterial
  4. 4.3.4 Epidural
  5. 4.3.5 Others
4. 4.4 Pharmaceutical, BY End-user (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Diagnostic centers
  4. 4.4.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Baxter International (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 B. Braun Melsungen AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medtronic (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Smiths Medical (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fresenius Kabi (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Terumo Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 ICU Medical (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Halyard Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Zyno Medical (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 CHINA MARKET ANALYSIS BY APPLICATION
4. 6.4 CHINA MARKET ANALYSIS BY MODE OF ADMINISTRATION
5. 6.5 CHINA MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY MODE OF ADMINISTRATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Pharmaceutical Market Segmentation

Pharmaceutical By Product Type (USD Million, 2025-2035)

Elastomeric infusion system
Disposable infusion system
Syringe infusion system
Peristaltic pump
Multi-channel pump
Patient-Controlled Analgesia (PCA) pump
Insulin pump
Implantable infusion system

Pharmaceutical By Application (USD Million, 2025-2035)

Oncology/Chemotherapy
Diabetes
Analgesia
Nutrition
Hematology
Pediatrics
Others

Pharmaceutical By Mode of administration (USD Million, 2025-2035)

Intravenous
Subcutaneous
Arterial
Epidural
Others

Pharmaceutical By End-user (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Diagnostic centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”